|
DE3508258A1
(de)
|
1985-03-08 |
1986-09-18 |
Bayer Ag, 5090 Leverkusen |
Ss-lactamantibiotika, verfahren zur herstellung und ihre verwendung als und in arzneimitteln
|
|
FR2643903A1
(fr)
|
1989-03-03 |
1990-09-07 |
Union Pharma Scient Appl |
Nouveaux derives de benzimidazole, leurs procedes de preparation, intermediaires de synthese, compositions pharmaceutiques les contenant, utiles notamment pour le traitement des maladies cardiovasculaires, et des ulceres duodenaux
|
|
RU1836357C
(ru)
|
1990-07-23 |
1993-08-23 |
Др.Карл Томэ ГмбХ |
Производные бензимидазола, их изомеры, смеси изомеров, гидраты или их физиологически переносимые соли, обладающие антагонистическими в отношении ангиотензина свойствами
|
|
DE4023369A1
(de)
|
1990-07-23 |
1992-01-30 |
Thomae Gmbh Dr K |
Benzimidazole, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
|
|
SI9210098B
(sl)
|
1991-02-06 |
2000-06-30 |
Dr. Karl Thomae |
Benzimidazoli, zdravila, ki te spojine vsebujejo, in postopek za njihovo pripravo
|
|
DE4224752A1
(de)
|
1992-04-11 |
1994-02-03 |
Thomae Gmbh Dr K |
Benzimidazole, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
|
|
DE4225756A1
(de)
|
1992-01-22 |
1994-03-10 |
Thomae Gmbh Dr K |
Benzimidazole, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
|
|
US5591762A
(en)
|
1991-02-06 |
1997-01-07 |
Dr. Karl Thomae Gmbh |
Benzimidazoles useful as angiotensin-11 antagonists
|
|
US5125961A
(en)
|
1991-08-12 |
1992-06-30 |
Monsanto Company |
Substituted pyridine compounds
|
|
DE4219534A1
(de)
|
1992-02-19 |
1993-12-16 |
Thomae Gmbh Dr K |
Substituierte Biphenylylderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
|
|
DE4408497A1
(de)
|
1994-03-14 |
1995-09-21 |
Thomae Gmbh Dr K |
Benzimidazole, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
|
|
JPH10503768A
(ja)
|
1994-08-02 |
1998-04-07 |
メルク シヤープ エンド ドーム リミテツド |
アゼチジン、ピロリジンおよびピペリジン誘導体
|
|
CN1072669C
(zh)
|
1995-04-21 |
2001-10-10 |
纽罗研究公司 |
苯并咪唑化合物及其用作gabaa受体复合物调节器的用途
|
|
JP2000072675A
(ja)
|
1998-08-26 |
2000-03-07 |
Tanabe Seiyaku Co Ltd |
医薬組成物
|
|
EP1144387A1
(en)
*
|
1998-12-04 |
2001-10-17 |
Neurosearch A/S |
New benzimidazolone-, benzoxazolone-, or benzothiazolone derivatives as ion channel modulating agents
|
|
US6380235B1
(en)
|
1999-05-04 |
2002-04-30 |
American Home Products Corporation |
Benzimidazolones and analogues
|
|
US6664252B2
(en)
|
1999-12-02 |
2003-12-16 |
Osi Pharmaceuticals, Inc. |
4-aminopyrrolo[2,3-d]pyrimidine compounds specific to adenosine A2a receptor and uses thereof
|
|
GB0002100D0
(en)
|
2000-01-28 |
2000-03-22 |
Novartis Ag |
Organic compounds
|
|
US20020019395A1
(en)
|
2000-02-01 |
2002-02-14 |
Bing-Yan Zhu |
Indalone and benzimidazolone inhibitors of factor Xa
|
|
US20120028912A1
(en)
|
2000-02-22 |
2012-02-02 |
J.David Gladstone Institute |
Methods of modulating bromodomains
|
|
CA2424768A1
(en)
|
2000-10-27 |
2002-09-06 |
Dow Agrosciences Llc |
Substituted 4,5-dihydro-1,2,4-triazin-6-ones, 1,2,4-triazin-6-ones, and their use as fungicides and insecticides
|
|
CN1263757C
(zh)
|
2000-12-01 |
2006-07-12 |
Osi制药公司 |
特异于腺苷a1,a2a和a3受体的化合物及其应用
|
|
ATE411292T1
(de)
|
2001-03-01 |
2008-10-15 |
Shionogi & Co |
Stickstoffhaltige heteroarylverbindungen mit hiv- integrase inhibierender wirkung
|
|
ATE309997T1
(de)
|
2001-03-09 |
2005-12-15 |
Pfizer Prod Inc |
Entzündungshemmende benzimidazolverbindungen
|
|
JP4251438B2
(ja)
|
2001-03-15 |
2009-04-08 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
Ｈｉｖ阻害性ピラジノン誘導体
|
|
PT1370553E
(pt)
|
2001-03-23 |
2006-09-29 |
Bayer Corp |
Inibidores de rhoquinase
|
|
RU2003131693A
(ru)
|
2001-03-28 |
2005-05-10 |
Бристол-Маерс Сквибб Компани (Us) |
Новые ингибиторы тирозин киназ
|
|
US7081454B2
(en)
|
2001-03-28 |
2006-07-25 |
Bristol-Myers Squibb Co. |
Tyrosine kinase inhibitors
|
|
WO2003068857A1
(en)
|
2002-02-15 |
2003-08-21 |
Bridgestone Corporation |
Rubber composition and pneumatic tire made therefrom
|
|
TWI276631B
(en)
|
2002-09-12 |
2007-03-21 |
Avanir Pharmaceuticals |
Phenyl-aza-benzimidazole compounds for modulating IgE and inhibiting cellular proliferation
|
|
AU2003294249A1
(en)
|
2002-11-08 |
2004-06-03 |
Trimeris, Inc. |
Hetero-substituted benzimidazole compounds and antiviral uses thereof
|
|
AR043063A1
(es)
|
2002-12-13 |
2005-07-13 |
Altana Pharma Ag |
Bencimidazoles 6-sustituidos y su uso como inhibidores de secreciones gastricas
|
|
AR042956A1
(es)
*
|
2003-01-31 |
2005-07-13 |
Vertex Pharma |
Inhibidores de girasa y usos de los mismos
|
|
CL2004000409A1
(es)
|
2003-03-03 |
2005-01-07 |
Vertex Pharma |
Compuestos derivados de 2-(cilo sustituido)-1-(amino u oxi sustituido)-quinazolina, inhibidores de canales ionicos de sodio y calcio dependientes de voltaje; composicion farmaceutica; y uso del compuesto en el tratamiento de dolor agudo, cronico, neu
|
|
EP1620413A2
(en)
|
2003-04-30 |
2006-02-01 |
Cytokinetics, Inc. |
Compounds, compositions, and methods
|
|
AU2003902860A0
(en)
|
2003-06-06 |
2003-06-26 |
Daicel Chemical Industries, Ltd |
Benzimidazole compounds
|
|
JP2007501618A
(ja)
|
2003-08-08 |
2007-02-01 |
アバニール・ファーマシューティカルズ |
タンパク質輸送の選択的薬理学的阻害、および関連した、ヒト疾患を治療する方法
|
|
NL1026826C2
(nl)
|
2003-08-13 |
2007-01-04 |
Pharmacia Corp |
Gesubstitueerde pyridinonen.
|
|
EP1720862A1
(en)
|
2004-02-03 |
2006-11-15 |
Eli Lilly And Company |
Kinase inhibitors
|
|
WO2005075432A1
(ja)
|
2004-02-06 |
2005-08-18 |
Chugai Seiyaku Kabushiki Kaisha |
１−（２ｈ）−イソキノロン誘導体およびその抗ガン剤としての使用
|
|
CN1285590C
(zh)
|
2004-02-23 |
2006-11-22 |
上海医药工业研究院 |
伊曲康唑盐酸盐口服固体组合物和制备方法
|
|
CA2559552A1
(en)
|
2004-03-23 |
2005-09-29 |
F. Hoffmann-La Roche Ag |
Benzyl-pyridazinone derivatives as non-nucleoside reverse transcriptase inhibitors
|
|
WO2005115399A2
(en)
|
2004-04-16 |
2005-12-08 |
Neurogen Corporation |
Imidazopyrazines, imidazopyridines, ans imidazopyrimidines as crf1 receptor ligands
|
|
AU2005249527B2
(en)
|
2004-06-01 |
2011-08-04 |
University Of Virginia Patent Foundation |
Dual small molecule inhibitors of cancer and angiogenesis
|
|
WO2005121132A1
(ja)
|
2004-06-11 |
2005-12-22 |
Shionogi & Co., Ltd. |
抗ｈｃｖ作用を有する縮合ヘテロ環化合物
|
|
MX2007001986A
(es)
|
2004-08-26 |
2007-05-10 |
Pfizer |
Compuestos de aminoheteroarilo como inhibidores de proteina quinasa.
|
|
GB0420719D0
(en)
|
2004-09-17 |
2004-10-20 |
Addex Pharmaceuticals Sa |
Novel allosteric modulators
|
|
GB0420722D0
(en)
|
2004-09-17 |
2004-10-20 |
Addex Pharmaceuticals Sa |
Novel allosteric modulators
|
|
WO2006038734A1
(en)
|
2004-10-08 |
2006-04-13 |
Astellas Pharma Inc. |
Pyridazinone derivatives cytokines inhibitors
|
|
EP2332527A3
(en)
|
2004-10-20 |
2011-11-16 |
Resverlogix Corp. |
Flavanoids and Isoflavanoids for the prevention and treatment of cardiovascular diseases
|
|
CA2596424C
(en)
|
2005-02-04 |
2016-03-29 |
Millennium Pharmaceuticals, Inc. |
Inhibitors of e1 activating enzymes
|
|
ES2400287T3
(es)
|
2005-03-14 |
2013-04-08 |
High Point Pharmaceuticals, Llc |
Derivados de benzazol, composiciones y procedimientos de uso como inhibidores de beta-secretasa
|
|
US7473669B2
(en)
|
2005-05-03 |
2009-01-06 |
Dow Agrosciences Llc |
Substituted 4,5-dihydro-1,2,4-triazin-6-ones, 1,2,4-triazin-6-ones, and their use as fungicides
|
|
CN101365446B
(zh)
|
2005-07-29 |
2013-05-22 |
雷斯弗洛吉克斯公司 |
预防和治疗复杂疾病的药物组合物及其经由可植入医药装置的递送
|
|
KR20080068839A
(ko)
|
2005-10-03 |
2008-07-24 |
오노 야꾸힝 고교 가부시키가이샤 |
질소 함유 복소환 화합물 및 그 의약 용도
|
|
JP2009515997A
(ja)
|
2005-11-18 |
2009-04-16 |
タケダ サン ディエゴ インコーポレイテッド |
グルコキナーゼ活性剤
|
|
EP1959951B1
(en)
*
|
2005-12-01 |
2009-12-23 |
F. Hoffmann-la Roche AG |
Heteroaryl substituted piperidine derivatives as l-cpt1 inhibitors
|
|
CN101384593A
(zh)
*
|
2006-02-17 |
2009-03-11 |
辉瑞有限公司 |
用作tlr7调节剂的3-脱氮嘌呤衍生物
|
|
EP1987030B1
(en)
*
|
2006-02-17 |
2011-11-09 |
Pfizer Limited |
3 -deazapurine derivatives as tlr7 modulators
|
|
WO2007117465A2
(en)
*
|
2006-03-31 |
2007-10-18 |
Abbott Laboratories |
Indazole compounds
|
|
WO2007113232A1
(en)
|
2006-04-03 |
2007-10-11 |
Glaxo Group Limited |
Azabicyclo [3. 1. 0] hexyl derivatives as modulators of dopamine d3 receptors
|
|
WO2008054599A2
(en)
|
2006-09-27 |
2008-05-08 |
Surface Logix, Inc. |
Rho kinase inhibitors
|
|
KR20090096690A
(ko)
|
2006-12-14 |
2009-09-14 |
아스텔라스세이야쿠 가부시키가이샤 |
Ｃｒｔｈ2 길항제 및 항알레르기제로 유용한 폴리사이클릭 산 화합물
|
|
SG144809A1
(en)
|
2007-01-11 |
2008-08-28 |
Millipore U K Ltd |
Benzimidazole compounds and their use as chromatographic ligands
|
|
NZ579355A
(en)
|
2007-02-01 |
2012-03-30 |
Resverlogix Corp |
2-(Aryl)-4-oxo-quinazoline derivatives
|
|
WO2008153701A1
(en)
|
2007-05-24 |
2008-12-18 |
Schering Corporation |
Compounds for inhibiting ksp kinesin activity
|
|
KR20100032886A
(ko)
*
|
2007-06-08 |
2010-03-26 |
아보트 러보러터리즈 |
키나제 억제제로서의 5-헤테로아릴 치환된 인다졸
|
|
EP2173721B1
(en)
|
2007-06-26 |
2011-12-28 |
Sanofi |
A regioselective copper catalyzed synthesis of benzimidazoles and azabenzimidazoles
|
|
DE102007032507A1
(de)
|
2007-07-12 |
2009-04-02 |
Merck Patent Gmbh |
Pyridazinonderivate
|
|
DE102007038957A1
(de)
|
2007-08-17 |
2009-02-19 |
Merck Patent Gmbh |
6-Thioxo-pyridazinderivate
|
|
GB0719235D0
(en)
|
2007-10-02 |
2007-11-14 |
Glaxo Group Ltd |
Novel compounds
|
|
WO2009054790A1
(en)
|
2007-10-26 |
2009-04-30 |
Astrazeneca Ab |
Amide linked heteroaromatic derivatives as modulators of mglur5
|
|
US8269009B2
(en)
|
2007-12-07 |
2012-09-18 |
Elan Pharmaceuticals, Inc. |
Methods and compositions for treating liquid tumors
|
|
US8084466B2
(en)
|
2007-12-18 |
2011-12-27 |
Janssen Pharmaceutica Nv |
Bicyclic heteroaryl-substituted imidazoles as modulators of the histamine H4 receptor
|
|
CN101910182B
(zh)
|
2007-12-28 |
2013-07-17 |
田边三菱制药株式会社 |
抗癌剂
|
|
TW200942537A
(en)
|
2008-02-01 |
2009-10-16 |
Irm Llc |
Compounds and compositions as kinase inhibitors
|
|
WO2009158258A1
(en)
|
2008-06-25 |
2009-12-30 |
E. I. Du Pont De Nemours And Company |
Herbicidal dihydro oxo six-membered azinyl isoxazolines
|
|
WO2010021693A2
(en)
*
|
2008-08-18 |
2010-02-25 |
Yale University |
Mif modulators
|
|
US9540322B2
(en)
*
|
2008-08-18 |
2017-01-10 |
Yale University |
MIF modulators
|
|
US9643922B2
(en)
|
2008-08-18 |
2017-05-09 |
Yale University |
MIF modulators
|
|
EP3037421A3
(en)
|
2008-11-25 |
2016-11-30 |
University Of Rochester |
Mlk inhibitors and methods of use
|
|
ES2548882T3
(es)
|
2008-12-08 |
2015-10-21 |
Arena Pharmaceuticals, Inc. |
Moduladores del receptor de prostaciclina (PGl2) útiles para el tratamiento de trastornos relacionados con los mismos
|
|
EP2196465A1
(en)
|
2008-12-15 |
2010-06-16 |
Almirall, S.A. |
(3-oxo)pyridazin-4-ylurea derivatives as PDE4 inhibitors
|
|
DE102008062826A1
(de)
|
2008-12-23 |
2010-07-01 |
Merck Patent Gmbh |
Pyridazinonderivate
|
|
US8389550B2
(en)
|
2009-02-25 |
2013-03-05 |
Hoffmann-La Roche Inc. |
Isoxazoles / O-pyridines with ethyl and ethenyl linker
|
|
AU2010222848A1
(en)
|
2009-03-09 |
2011-10-20 |
Surface Logix, Inc. |
Rho kinase inhibitors
|
|
CN105859639A
(zh)
|
2009-03-18 |
2016-08-17 |
雷斯韦洛吉克斯公司 |
新的抗炎剂
|
|
EP2408449A4
(en)
|
2009-03-18 |
2012-08-08 |
Univ Leland Stanford Junior |
METHOD AND COMPOSITIONS FOR TREATING FLAVIVIRIDAE VIRUS INFECTIONS
|
|
JP5813626B2
(ja)
|
2009-04-22 |
2015-11-17 |
レスバーロジックス コーポレイション |
新規抗炎症剤
|
|
AU2010244553A1
(en)
|
2009-05-05 |
2011-12-01 |
F. Hoffmann-La Roche Ag |
Isoxazole-pyridine derivatives
|
|
GB0919431D0
(en)
|
2009-11-05 |
2009-12-23 |
Glaxosmithkline Llc |
Novel compounds
|
|
GB0919432D0
(en)
|
2009-11-05 |
2009-12-23 |
Glaxosmithkline Llc |
Use
|
|
GB0919423D0
(en)
|
2009-11-05 |
2009-12-23 |
Glaxosmithkline Llc |
Novel compounds
|
|
GB0919434D0
(en)
|
2009-11-05 |
2009-12-23 |
Glaxosmithkline Llc |
Novel compounds
|
|
BR112012010706A2
(pt)
|
2009-11-05 |
2016-03-29 |
Glaxosmithkline Llc |
composto, composição farmacêutica, combinação do produto farmacêutico, uso de um composto, e, métodos para o tratamento de uma doença ou condição, e para inibir um bromodomínio
|
|
WO2011054845A1
(en)
|
2009-11-05 |
2011-05-12 |
Glaxosmithkline Llc |
Benzodiazepine bromodomain inhibitor
|
|
KR101122606B1
(ko)
|
2009-11-20 |
2012-03-16 |
에스케이케미칼주식회사 |
고나도트로핀 방출 호르몬 수용체 길항제, 이의 제조방법 및 이를 함유하는 약제학적 조성물
|
|
JP2013512880A
(ja)
*
|
2009-12-03 |
2013-04-18 |
グラクソ グループ リミテッド |
Ｐｉ３−キナーゼ阻害剤としてのインダゾール誘導体
|
|
US20130085133A1
(en)
|
2010-02-08 |
2013-04-04 |
Sourthern Research Institute Office of Commercialization and Intellectual Prop. |
Anti-viral treatment and assay to screenfor anti-viral agent
|
|
KR101165996B1
(ko)
|
2010-04-23 |
2012-07-18 |
주식회사 녹십자 |
프탈라지논 유도체, 이의 제조방법 및 이를 함유하는 약학적 조성물
|
|
BR112012029005A2
(pt)
|
2010-05-14 |
2016-07-26 |
Dana Farber Cancer Inst Inc |
composições e métodos de tratamento de neoplasia, doença inflamatória e outros distúrbios
|
|
JP2011246389A
(ja)
*
|
2010-05-26 |
2011-12-08 |
Oncotherapy Science Ltd |
Ｔｔｋ阻害作用を有する縮環ピラゾール誘導体
|
|
CA2810162A1
(en)
|
2010-06-09 |
2011-12-15 |
Rutgers, The State University Of New Jersey |
Antimicrobial agents
|
|
WO2011159926A1
(en)
|
2010-06-16 |
2011-12-22 |
Rutgers, The State University Of New Jersey |
Antimicrobial agents
|
|
US20130165426A1
(en)
|
2010-07-06 |
2013-06-27 |
Université de Montréal |
Imidazopyridine, imidazopyrimidine and imidazopyrazine derivatives as melanocortin-4 receptor modulators
|
|
WO2012009258A2
(en)
|
2010-07-13 |
2012-01-19 |
Edward Roberts |
Peptidomimetic galanin receptor modulators
|
|
WO2012021382A1
(en)
*
|
2010-08-12 |
2012-02-16 |
Merck Sharp & Dohme Corp. |
Positive allosteric modulators of mglur2
|
|
WO2012040499A2
(en)
|
2010-09-22 |
2012-03-29 |
Surface Logix, Inc. |
Metabolic inhibitors
|
|
KR101242572B1
(ko)
|
2010-10-12 |
2013-03-19 |
한국화학연구원 |
5-환 헤테로 아릴로 치환된 프탈라지논 유도체 또는 이의 약학적으로 허용가능한 염, 이의 제조방법 및 이를 유효성분으로 포함하는 약학적 조성물
|
|
GB201018147D0
(en)
|
2010-10-27 |
2010-12-08 |
Glaxo Group Ltd |
Method of treatment
|
|
AR084070A1
(es)
|
2010-12-02 |
2013-04-17 |
Constellation Pharmaceuticals Inc |
Inhibidores del bromodominio y usos de los mismos
|
|
US9249161B2
(en)
|
2010-12-02 |
2016-02-02 |
Constellation Pharmaceuticals, Inc. |
Bromodomain inhibitors and uses thereof
|
|
CN102731409A
(zh)
|
2011-04-08 |
2012-10-17 |
中国科学院上海药物研究所 |
一类哒嗪酮类化合物，其药物组合物、制备方法及用途
|
|
GB201106743D0
(en)
|
2011-04-21 |
2011-06-01 |
Glaxosmithkline Llc |
Novel compounds
|
|
GB201106799D0
(en)
|
2011-04-21 |
2011-06-01 |
Glaxosmithkline Llc |
Novel compounds
|
|
GB201106750D0
(en)
|
2011-04-21 |
2011-06-01 |
Glaxosmithkline Llc |
Novel compounds
|
|
GB201107325D0
(en)
|
2011-05-04 |
2011-06-15 |
Glaxosmithkline Llc |
Novel compounds
|
|
WO2012174487A2
(en)
*
|
2011-06-17 |
2012-12-20 |
Constellation Pharmaceuticals, Inc. |
Bromodomain inhibitors and uses thereof
|
|
GB201114103D0
(en)
|
2011-08-17 |
2011-09-28 |
Glaxosmithkline Llc |
Novel compounds
|
|
WO2013027168A1
(en)
|
2011-08-22 |
2013-02-28 |
Pfizer Inc. |
Novel heterocyclic compounds as bromodomain inhibitors
|
|
JP5878178B2
(ja)
*
|
2011-09-30 |
2016-03-08 |
大鵬薬品工業株式会社 |
１，２，４−トリアジン−６−カルボキサミド誘導体
|
|
RU2640115C2
(ru)
|
2011-11-01 |
2017-12-26 |
Ресверлоджикс Корп. |
Фармацевтические композиции замещенных хиназолинонов
|
|
JP6141863B2
(ja)
|
2011-12-01 |
2017-06-07 |
ケモセントリックス，インコーポレイティド |
Ｃｃｒ（４）アンタゴニストとしての置換ベンズイミダゾール及びベンゾピラゾール
|
|
WO2013097052A1
(en)
|
2011-12-30 |
2013-07-04 |
Abbott Laboratories |
Bromodomain inhibitors
|
|
US20130281396A1
(en)
|
2012-04-19 |
2013-10-24 |
Rvx Therapeutics Inc. |
Treatment of diseases by epigenetic regulation
|
|
US20130281397A1
(en)
|
2012-04-19 |
2013-10-24 |
Rvx Therapeutics Inc. |
Treatment of diseases by epigenetic regulation
|
|
US20130281398A1
(en)
|
2012-04-19 |
2013-10-24 |
Rvx Therapeutics Inc. |
Treatment of diseases by epigenetic regulation
|
|
US20130281399A1
(en)
|
2012-04-19 |
2013-10-24 |
Rvx Therapeutics Inc. |
Treatment of diseases by epigenetic regulation
|
|
MX2014012635A
(es)
|
2012-04-20 |
2015-05-15 |
Abbvie Inc |
Derivados de isoindolona.
|
|
US9624244B2
(en)
|
2012-06-06 |
2017-04-18 |
Constellation Pharmaceuticals, Inc. |
Benzo [B] isoxazoloazepine bromodomain inhibitors and uses thereof
|
|
CA2874303C
(en)
|
2012-06-11 |
2020-10-13 |
Ucb Biopharma Sprl |
Tnf -alpha modulating benz imidazoles
|
|
US20140073634A1
(en)
|
2012-08-24 |
2014-03-13 |
Institute For Applied Cancer Science/The University of Texas MD Anderson Cancer Center |
Heterocyclic modulators of hif activity for treatment of disease
|
|
AU2013311826A1
(en)
|
2012-09-05 |
2015-03-26 |
Bayer Cropscience Ag |
Use of substituted 2-amidobenzimidazoles, 2-amidobenzoxazoles and 2-amidobenzothiazoles or salts thereof as active substances against abiotic plant stress
|
|
US20150246888A1
(en)
|
2012-09-11 |
2015-09-03 |
Michael Johnson |
Enoyl reductase inhibitors with antibacterial activity
|
|
WO2014078257A1
(en)
|
2012-11-14 |
2014-05-22 |
Glaxosmithkline Llc |
Thieno[3,2-c]pyridin-4(5h)-ones as bet inhibitors
|
|
US9765039B2
(en)
|
2012-11-21 |
2017-09-19 |
Zenith Epigenetics Ltd. |
Biaryl derivatives as bromodomain inhibitors
|
|
US9073878B2
(en)
|
2012-11-21 |
2015-07-07 |
Zenith Epigenetics Corp. |
Cyclic amines as bromodomain inhibitors
|
|
JP2016509576A
(ja)
|
2012-12-20 |
2016-03-31 |
バイエル ファーマ アクチエンゲゼルシャフト |
Ｂｅｔタンパク質阻害性ジヒドロキノキザリノン類
|
|
CN105073744B
(zh)
|
2012-12-21 |
2019-11-08 |
齐尼思表观遗传学有限公司 |
作为溴结构域抑制剂的新型杂环化合物
|
|
US20160009725A1
(en)
|
2013-02-22 |
2016-01-14 |
Bayer Pharma Aktiengesellschaft |
Pyrrolo- and pyrazolo-triazolodiazepines as bet-protein inhibitors for treating hyperproliferative diseases
|
|
CA2901805A1
(en)
|
2013-02-22 |
2014-08-28 |
Bayer Pharma Aktiengesellschaft |
4-substituted pyrrolo- and pyrazolo-diazepines
|
|
WO2014128655A1
(en)
|
2013-02-25 |
2014-08-28 |
Aurigene Discovery Technologies Limited |
Substituted imidazo[4,5-c]quinoline derivatives as bromodomain inhibitors
|
|
US9492460B2
(en)
|
2013-02-27 |
2016-11-15 |
Bristol-Myers Squibb Company |
Carbazole compounds useful as bromodomain inhibitors
|
|
CN105189488B
(zh)
|
2013-02-27 |
2018-07-24 |
百时美施贵宝公司 |
用作溴区结构域抑制剂的咔唑化合物
|
|
JP6401773B2
(ja)
|
2013-03-11 |
2018-10-10 |
ザ リージェンツ オブ ザ ユニヴァシティ オブ ミシガン |
Ｂｅｔブロモドメイン阻害剤およびこれを用いる治療方法
|
|
US9050346B2
(en)
|
2013-03-11 |
2015-06-09 |
Abbvie Inc. |
Bromodomain inhibitors
|
|
CA2904049A1
(en)
|
2013-03-11 |
2014-10-09 |
Abbvie Inc. |
Fused tetracyclic bromodomain inhibitors
|
|
JP2016512542A
(ja)
|
2013-03-12 |
2016-04-28 |
アッヴィ・インコーポレイテッド |
ピロールアミド阻害剤
|
|
TW201443051A
(zh)
|
2013-03-12 |
2014-11-16 |
Abbvie Inc |
二氫－吡咯并吡啶酮抑制劑
|
|
CN105407894A
(zh)
|
2013-03-14 |
2016-03-16 |
康威基内有限公司 |
用于抑制含布罗莫结构域的蛋白质的方法和组合物
|
|
CN105189515B
(zh)
|
2013-03-14 |
2018-07-03 |
葛兰素史克知识产权第二有限公司 |
作为溴结构域抑制剂的呋喃并吡啶类
|
|
CA2901537C
(en)
|
2013-03-14 |
2021-09-07 |
Glaxosmithkline Intellectual Property (No.2) Limited |
2,3-disubstituted 1- acyl-4-amino-1 ,2,3,4-tetrahydroquinoline derivatives and their use as bromodomain inhibitors
|
|
SMT201800650T1
(it)
|
2013-03-15 |
2019-01-11 |
Plexxikon Inc |
Composti eterociclici e loro impiego
|
|
US20140303121A1
(en)
|
2013-03-15 |
2014-10-09 |
Plexxikon Inc. |
Heterocyclic compounds and uses thereof
|
|
AU2014236606A1
(en)
|
2013-03-15 |
2015-09-24 |
Epigenetix, Inc. |
Oxazolo(5,4-c)quinolin-2-one compounds as bromodomain inhibitors
|
|
BR112015022942B1
(pt)
|
2013-03-15 |
2022-02-22 |
Incyte Holdings Corporation |
Compostos heterocíciclos tricíclicos, método para inibir proteína bet in vitro e composição farmacêutica compreendendo os referidos compostos
|
|
EP2978757B1
(en)
|
2013-03-27 |
2017-02-08 |
Boehringer Ingelheim International GmbH |
Indolinone analogues as brd4 inhibitors
|
|
WO2014154762A1
(en)
|
2013-03-27 |
2014-10-02 |
Boehringer Ingelheim International Gmbh |
Dihydroquinazolinone analogues as brd4 inhibitors
|
|
TWI530499B
(zh)
|
2013-03-28 |
2016-04-21 |
吉李德科學股份有限公司 |
作為溴結構域（ｂｒｏｍｏｄｏｍａｉｎ）抑制劑之苯並咪唑酮衍生物類
|
|
EP2792355A1
(en)
|
2013-04-17 |
2014-10-22 |
Albert-Ludwigs-Universität Freiburg |
Compounds for use as bromodomain inhibitors
|
|
WO2014170350A1
(en)
|
2013-04-17 |
2014-10-23 |
Albert Ludwigs Universität Freiburg |
Compounds for use as bromodomain inhibitors
|
|
EA027139B1
(ru)
|
2013-04-26 |
2017-06-30 |
Бейджин, Лтд. |
Замещенные 5-(3,5-диметилизоксазол-4-ил)индолин-2-оны
|
|
TWI527811B
(zh)
|
2013-05-09 |
2016-04-01 |
吉李德科學股份有限公司 |
作爲溴結構域抑制劑的苯並咪唑衍生物
|
|
US8975417B2
(en)
|
2013-05-27 |
2015-03-10 |
Novartis Ag |
Pyrazolopyrrolidine derivatives and their use in the treatment of disease
|
|
KR20160012194A
(ko)
|
2013-05-27 |
2016-02-02 |
노파르티스 아게 |
이미다조피롤리디논 유도체 및 질환의 치료에서의 그의 용도
|
|
EP3010909A1
(de)
|
2013-06-17 |
2016-04-27 |
Bayer Pharma Aktiengesellschaft |
Substituierte phenyl-2,3-benzodiazepine
|
|
SG10201710705UA
(en)
|
2013-06-21 |
2018-02-27 |
Zenith Epigenetics Ltd |
Novel bicyclic bromodomain inhibitors
|
|
WO2015004533A2
(en)
|
2013-06-21 |
2015-01-15 |
Zenith Epigenetics Corp. |
Novel substituted bicyclic compounds as bromodomain inhibitors
|
|
AR096758A1
(es)
|
2013-06-28 |
2016-02-03 |
Abbvie Inc |
Inhibidores cristalinos de bromodominios
|
|
ES2635560T3
(es)
|
2013-07-08 |
2017-10-04 |
Incyte Holdings Corporation |
Heterociclos tricíclicos como inhibidores de la proteína NET
|
|
WO2015011084A1
(de)
|
2013-07-23 |
2015-01-29 |
Bayer Pharma Aktiengesellschaft |
Substituierte dihydropyrido[3,4-b]pyrazinone als duale inhibitoren von bet-proteinen und polo-like kinasen
|
|
BR112016001457A2
(pt)
|
2013-07-25 |
2017-08-29 |
Dana Farber Cancer Inst Inc |
Inibidores de fatores de transcrição e usos dos mesmos
|
|
EP3027604B1
(en)
|
2013-07-31 |
2019-02-20 |
Zenith Epigenetics Ltd. |
Novel quinazolinones as bromodomain inhibitors
|
|
US20150051208A1
(en)
|
2013-08-14 |
2015-02-19 |
Boehringer Ingelheim International Gmbh |
Pyridinones
|
|
MX370535B
(es)
|
2013-11-18 |
2019-12-17 |
Forma Therapeutics Inc |
Compuestos de tetrahidroquinolina como inhibidores del bromodominio extra terminal y bromo (bet) y el uso de los mismos en el tratamiento de cáncer.
|
|
WO2015074081A1
(en)
|
2013-11-18 |
2015-05-21 |
Bair Kenneth W |
Benzopiperazine compositions as bet bromodomain inhibitors
|
|
GB201321739D0
(en)
|
2013-12-09 |
2014-01-22 |
Ucb Pharma Sa |
Therapeutic agents
|
|
US9458156B2
(en)
|
2014-12-23 |
2016-10-04 |
Bristol-Myers Squibb Company |
Tricyclic compounds as anticancer agents
|
|
HK1246273B
(en)
|
2014-12-01 |
2019-12-06 |
恒翼生物医药(上海)股份有限公司 |
Substituted pyridines as bromodomain inhibitors
|
|
HK1245246A1
(zh)
|
2014-12-01 |
2018-08-24 |
恒翼生物医药科技(上海)有限公司 |
作为溴域抑制剂的取代吡啶酮
|
|
JP2017537946A
(ja)
|
2014-12-11 |
2017-12-21 |
ゼニス・エピジェネティクス・リミテッドＺｅｎｉｔｈ Ｅｐｉｇｅｎｅｔｉｃｓ Ｌｔｄ． |
ブロモドメイン阻害剤としての置換複素環
|
|
CA2966450A1
(en)
|
2014-12-17 |
2016-06-23 |
Olesya KHARENKO |
Inhibitors of bromodomains
|
|
CA2966452A1
(en)
|
2014-12-17 |
2016-06-23 |
Samuel David Brown |
Substituted bicyclic compounds as bromodomain inhibitors
|